Video
Vyluma announces NMPA of China accepts drug application of NVK002 (low-dose atropine 0.01%) for myopia progression in children
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Harrow launches Harrow Cares program in partnership with Cencora
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
ARVO Foundation reveals 2025 Dr David L Epstein Award recipients
Viralgen and Axovia Therapeutics partner to manufacture gene therapy for Bardet-Biedl Syndrome